πŸ‡ΊπŸ‡Έ FDA
Patent

US 9896432

Somatostatin modulators and uses thereof

granted A61PA61P11/00A61P13/12

Quick answer

US patent 9896432 (Somatostatin modulators and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRINETICS PHARMACEUTICALS, INC.
Grant date
Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P11/00, A61P13/12, A61P25/00, A61P25/04